Campbell Alliance Workshop at Clinical Trials Congress to Focus on Redesigning Clinical Trial Processes to Maximize EDC Technologies

February 9, 2006


Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that Tim Dietlin, Senior Practice Executive in the Clinical Development Practice, will facilitate a three-hour workshop at the Institute for Institutional Research’s (IIR) Clinical Trials Congress to be held February 13-15, 2006 at the Caribe Royale All Suites Resort in Orlando.


The workshop, titled “Redesigning Your Organization’s Clinical Development Processes to Maximize the Benefit of Electronic Data Capture (EDC) Technologies,” will focus on an approach pharmaceutical and biotech companies can apply to restructure their organization’s internal clinical development processes to make the most effective use of EDC technologies.  It will also cover strategies for developing goals and metrics to maximize return-on-investment, as well as methods for training internal staff members.  The workshop will be conducted on February 13 from 2:00 p.m. to 5:00 p.m.


Mr. Dietlin leads Campbell Alliance’s specialty practice dedicated to helping companies realize the benefits of EDC technologies, including developing EDC strategies, navigating the technology vendor landscape, and redesigning clinical development processes and organization structures to leverage investments in EDC technology.


“We’re seeing a significant shift in how the pharma and biotech industries view EDC overall.  Most companies we’ve worked with now view it not only as a technology implementation, but as a major change in the way they conduct clinical trials,” says Dietlin.  “Our team has helped execute some of the industry’s largest and most complex EDC implementations.  The extent of these changes—from identifying process change specifications to reviewing and analyzing data throughout clinical trials—have been necessary for companies to realize the full benefits of their EDC investments,” he continued.


According to IIR, the Clinical Trials Congress is the only event where senior level clinical professionals and industry experts challenge the status quo to achieve process optimization and increase efficiency in drug development.  The three-day event will include presentations, workshops, and panel discussions with the involvement of over 100 clinical experts.  For more information, please visit  



About the Clinical Development Practice at Campbell Alliance


Campbell Alliance’s Clinical Development Practice includes operations improvement specialists with expertise in clinical development. This practice specializes in helping clients correct or improve the processes that are most often responsible for delays and budget overruns in clinical development.  Services include


  • Development of outsourcing strategies
  • Process improvement for data collection and management, patient recruitment, and project management
  • Organizational development and improvement
  • Electronic data management consulting and implementation support
  • Clinical trial analytics


About Campbell Alliance


Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries.  The firm's clients include most of the world's "top 20" pharmaceutical companies, as well as numerous emerging and midsize firms.  Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales.  From its locations in Raleigh, N.C., Parsippany, N.J., Woodland Hills, Calif., San Bruno, Calif., and New York City, the firm serves clients throughout North America, Europe, and Japan.  For more information on Campbell Alliance, please visit

inVentiv Health Consulting offers world class healthcare consulting services.

Media Contact:

Stephanie Koenig